Danish Queen Margrethe has awarded the prestigious Dronning Ingrid’s Research Prize to physiotherapist and professor Inger Mechlenburg for her groundbreaking work in improving treatment options and quality of life for patients with joint and muscular diseases.
Prestigious Recognition at Fredensborg Palace
On Monday morning, Her Majesty Queen Margrethe of Denmark presented the 2025 Dronning Ingrid’s Research Prize to Inger Mechlenburg, a professor and physiotherapist renowned for her contributions to arthritis research. The award ceremony took place at the historical Fredensborg Palace, in the elegant Garden Hall beneath grand chandeliers, marking a significant milestone in the professional life of the Aarhus University professor.
The award, which includes a grant of 250,000 Danish kroner (approximately $35,000), is one of Denmark’s most prestigious health science honors. It was established in 1978 to commemorate Queen Ingrid’s 25-year service as patron of the Danish Rheumatism Association (Gigtforeningen). The prize is aimed at supporting further research and promoting innovative approaches to arthritis care, particularly patient-centered treatments such as physiotherapy and surgical alternatives.
Revolutionizing Arthritis Treatment
Professor Inger Mechlenburg graduated as a physiotherapist in 1998 from Holstebro, earned her PhD in 2016, and was appointed professor at Aarhus University in 2017. Over the past two decades, she has emerged as a leading figure in the field of musculoskeletal disorders, helping to reshape how physiotherapy is integrated into arthritis management.
Backed by sound scientific rigour, Mechlenburg’s research bridges the gap between clinical surgery and everyday rehabilitation. Her work concentrates on practical, effective alternatives to major surgeries and empowers patients by giving them more involvement in their own treatment plans. This dual approach has been instrumental in redefining the care model for over 700,000 Danes living with joint, back, and muscle conditions.
One of the key findings from her research illustrates that structured physical therapy can, in certain cases, serve as a viable alternative to surgery. For those who must undergo surgery, tailored exercise programs both before and after the procedure have proven to significantly enhance functionality and elevate quality of life.
Empowering Patients through Science
Mechlenburg is celebrated not only for her academic excellence, but also for her commitment to patient-oriented care. Her studies stress the importance of giving arthritis patients a voice in their treatment trajectories, thereby shifting the traditional health care dynamic from a passive to a participatory model.
This empowerment offers tangible benefits. Research led by Mechlenburg demonstrates that patient involvement and physiotherapy-centric care routines can reduce dependency on surgical interventions and prescription medications. Moreover, measurable outcomes include improved mobility and reduced psychological distress, which often accompanies chronic illness.
Globally, arthritis and related disorders account for significant personal and economic burdens. In Denmark alone, more than 100,000 people live with inflammatory arthritis, and musculoskeletal diseases collectively represent one of the country’s largest categories of long-term disability.
About the Danish Rheumatism Association
Founded in 1936, the Danish Rheumatism Association (Gigtforeningen) is a non-profit patient advocacy organization representing more than 80,000 members and supporters. Its mission is to promote research, awareness, and support for those affected by rheumatic diseases. The organization serves a vital role in initiating public health dialogues, funding medical innovation, and partnering with clinicians and researchers to improve disease management strategies across Denmark.
Over the last several years, Gigtforeningen’s emphasis on holistic and interdisciplinary care has resulted in strong collaboration between researchers like Mechlenburg and institutions such as Danish national hospitals and rehabilitation centers.
A Vision for the Future
Mechlenburg’s recognition with Dronning Ingrid’s Research Prize confirms both her scientific impact and her dedication to transforming arthritis treatment in Denmark. With the additional funding from the award, she is expected to continue her research into developing more personalized, effective, and non-invasive treatments for musculoskeletal disorders.
As the prevalence of these conditions continues to rise both domestically and worldwide, Mechlenburg’s work stands as a beacon of progress – combining academic rigor with genuine compassion and a patient-first perspective. Her achievements not only bring hope to thousands suffering from chronic pain but also inspire future innovations within Denmark’s robust medical research community.
